Connect with us

Cannabis News

Public Meetings In Mexico Will Soon Discuss The Legalization And Regulation Of Marijuana



  • At least three public meetings will be hosted by the Mexican Senate to deliberate on the regulation of cannabis.
  • The public will have the option of registering for attendance and submitting their own input.

Marijuana regulation has become a major topic around the world, and Mexico is joining the discussion. The Mexican Senate announced on Tuesday that their lawmakers will be collaborating through multiple public meetings this month, hoping to create policies for the legalization and regulation of marijuana. The public meetings are presently planned to take place on August 12th, 14th, and 16th.

The hearings will offer a platform for members of the public to weigh in on the five factors that are involved with every proposal for reform:

  • Human rights considerations
  • Public health issues
  • Dealing with addition
  • Preventing underage consumption
  • Creating medications with cannabis

Last year, the Mexican Supreme Court stated that the prohibition of cannabis for personal use is constitutional, which is why the government needs to make this conversation a public discussion. Translated from a government website, the hearing aims to establish regulations “with an approach of absolute transparency and free participation” that’s “acceptable to the whole society in open parliament, in person or online.”

There’s presently a page available for information regarding these public meetings, created by the Senate. Individuals have the ability to register for their own attendance through August 15th, and input can be submitted from the website. Presently, there have already been multiple pieces of legislation introduced in the country to legalize cannabis.

Before any of the proposals are acted upon, the committees have an obligation to;

“Initiate various legislative activities of open parliament…in order to know and listen to the opinions that they reflect the environment and the feeling of society with respect to such an important issue and, with that, contribute to obtaining a regulation according to the reality of our country.”

Only a few months ago, Julio Ramón Menchaca Salazar, leader of Mexico’s Senate Justice Committee, stated that the panel would be engaging in a recess period over the summertime for the creation of this legislation. The parliament has at least 10 cannabis reform proposals to examine, but the most likely to pass is a proposal by Secretary of the Interior Olga Sanchez Cordero. The proposal states that up to 20 mature cannabis plants could be grown by an individual at once for personal consultation on their property, among other concerns.

As part of a “National Development Plan,” President Andrés Manuel López Obrador commented several months ago that prohibiting this substance is ultimately “unsustainable.” Instead, his plan proposed decriminalization.

Arina has a Master’s degree in Business and lives in Sydney, Australia and is one of our top contributors as a postgraduate qualified writer. While being a Member Of The Appraisal Institute, she focuses her writing efforts on health, home, business, technology and now cannabis/cbd here.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.